The Boston Red Sox entered the trade deadline looking to add depth at shortstop, and they settled on a deal that sent promising arm Connelly Early to the opposing club in exchange for infielder Curtis Mead, hoping to bolster their roster.
A costly deadline gamble
Mead’s tenure in Boston got off to a disastrous start when, in his second appearance, he fractured his wrist, a blow that not only ended his rookie campaign but also forced a lengthy rehabilitation period typical of such injuries.
Mead had been enjoying a breakout year before the injury, posting a 1.6 WAR and a 64 wRC+ that hinted at a player ready to contribute immediately, but his 41-game stint with the White Sox in 2023 ended with a negative 0.3 WAR, underscoring the volatility of the move.
The Red Sox are not alone in seeing a high‑profile deadline acquisition collapse; similar outcomes have plagued other contending clubs, from Andrew Cashner’s underwhelming stint with the Marlins in 2016 to Nelson Cruz’s sharp decline after a trade to the Rays in 2021.
More recent examples include Miguel Vargas, whose -1.16 WAR with the White Sox in 2024 marked the worst performance after a deadline deal, and Bryan De La Cruz, whose production dipped after a move to the Pirates, while Willi Castro was hailed as the most impactful piece traded in 2025 before his own contributions faded.
Even veteran pieces like Eduardo Escobar and Mike Moustakas have combined to cost the Angels a collective -1.6 WAR after a 2023 trade, illustrating a pattern that teams rarely escape without at least one costly misstep.
For Boston, the episode serves as a reminder that the trade market is a gamble, and while the front office, led by Craig Breslow, will look to rebound, the lesson is clear: a single injury or underperformance can turn a hopeful upgrade into a net loss.